Associations - EGFR C797S + EGFR T790M + EGFR exon 19 deletion

EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	CH7233163 Sensitive: D – Preclinical	CH7233163 Sensitive: D – Preclinical
EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	osimertinib + BLU-945 Sensitive: D – Preclinical	osimertinib + BLU-945 Sensitive: D – Preclinical
EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	panitumumab + WX-0593 Sensitive: D – Preclinical	panitumumab + WX-0593 Sensitive: D – Preclinical
EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	TAS3351 Sensitive: D – Preclinical	TAS3351 Sensitive: D – Preclinical
EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	EGFR C797S + EGFR T790M + EGFR exon 19 deletion EGFR C797S + EGFR T790M + EGFR exon 19 deletion	Non Small Cell Lung Cancer NSCLC	H002 Sensitive: D – Preclinical	H002 Sensitive: D – Preclinical